P203 Late antibody-mediated rejection (ABMR) after kidney transplantation – Role of the eGFR slope within the first year after biopsy as a surrogate endpoint predicting graft failure.

Highlights from the article: P203 Late antibody-mediated rejection (ABMR) after kidney transplantation - Role of the eGFR slope within the first year after biopsy as a surrogate endpoint predicting graft failure There is currently no effective, evidence-proven treatment for late ABMR. Median eGFR at the time of biopsy was 42 mL/min/1.73 m SP 2 sp (IQR: 39-45) and the median eGFR slope (first 12 months after ABMR diagnosis) was -4.4 mL/min/1.73 m SP 2 sp .